» Articles » PMID: 18573035

Nonresponse and Dropout Rates in Outcome Studies on PTSD: Review and Methodological Considerations

Overview
Journal Psychiatry
Specialty Psychiatry
Date 2008 Jun 25
PMID 18573035
Citations 180
Authors
Affiliations
Soon will be listed here.
Abstract

Post-traumatic stress disorder (PTSD) represents a frequent consequence of a variety of extreme psychological stressors. Lists of empirically supported treatments for PTSD usually include cognitive behavioral therapy (CBT) and eye movement desensitization and reprocessing (EMDR), but nonresponse and dropout rates in these treatments often are high. We review the treatment dropout and nonresponse rates in 55 studies of empirically supported treatments for PTSD, review the literature for predictors of dropout and nonresponse, discuss methodological inconsistencies in the literature that make comparisons across studies difficult, and outline future directions for research. Dropout rates ranged widely and may have depended, at least in part, on the nature of the study population. It was not uncommon to find nonresponse rates as high as 50%. Standard methods of reporting dropout and nonresponse rates are needed for reporting outcomes. We suggest guidelines for collecting data to help identify characteristics and predictors of dropouts and nonresponders.

Citing Articles

Prebiotics as an adjunct therapy for posttraumatic stress disorder: a pilot randomized controlled trial.

Voigt R, Engen P, Villanueva M, Bambi S, Green S, Naqib A Front Neurosci. 2025; 18:1477519.

PMID: 39840022 PMC: 11747240. DOI: 10.3389/fnins.2024.1477519.


MDMA for PTSD and beyond: a new paradigm brings hope.

Shannon S, Geller J Front Hum Neurosci. 2024; 18:1475013.

PMID: 39723418 PMC: 11669054. DOI: 10.3389/fnhum.2024.1475013.


Neural activity during working memory predicts clinical response to computerized executive function training prior to cognitive processing therapy.

Davey D, Caudle M, Hoffman S, Jak A, Bomyea J, Crocker L Psychol Med. 2024; :1-10.

PMID: 39679550 PMC: 11779553. DOI: 10.1017/S0033291724003106.


The Role of Implicit Memory in the Development and Recovery from Trauma-Related Disorders.

Damis L NeuroSci. 2024; 3(1):63-88.

PMID: 39484673 PMC: 11523743. DOI: 10.3390/neurosci3010005.


MDMA for treatment of PTSD and neurorehabilitation in military populations.

Dunn W, Bershad A, Krantz D, Vermetten E NeuroRehabilitation. 2024; 55(3):357-368.

PMID: 39331116 PMC: 11612990. DOI: 10.3233/NRE-230270.